Zhejiang Hisoar (China) Probability of Future Stock Price Finishing Under 5.71

002099 Stock   5.95  0.03  0.51%   
Zhejiang Hisoar's future price is the expected price of Zhejiang Hisoar instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Zhejiang Hisoar Pharmaceutical performance during a given time horizon utilizing its historical volatility. Check out Zhejiang Hisoar Backtesting, Zhejiang Hisoar Valuation, Zhejiang Hisoar Correlation, Zhejiang Hisoar Hype Analysis, Zhejiang Hisoar Volatility, Zhejiang Hisoar History as well as Zhejiang Hisoar Performance.
  
Please specify Zhejiang Hisoar's target price for which you would like Zhejiang Hisoar odds to be computed.

Zhejiang Hisoar Target Price Odds to finish below 5.71

The tendency of Zhejiang Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to  5.71  or more in 90 days
 5.95 90 days 5.71 
about 42.3
Based on a normal probability distribution, the odds of Zhejiang Hisoar to drop to  5.71  or more in 90 days from now is about 42.3 (This Zhejiang Hisoar Pharmaceutical probability density function shows the probability of Zhejiang Stock to fall within a particular range of prices over 90 days) . Probability of Zhejiang Hisoar Phar price to stay between  5.71  and its current price of 5.95 at the end of the 90-day period is about 25.2 .
Assuming the 90 days trading horizon Zhejiang Hisoar Pharmaceutical has a beta of -0.92. This suggests Additionally Zhejiang Hisoar Pharmaceutical has an alpha of 0.3594, implying that it can generate a 0.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Zhejiang Hisoar Price Density   
       Price  

Predictive Modules for Zhejiang Hisoar

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zhejiang Hisoar Phar. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
2.955.958.95
Details
Intrinsic
Valuation
LowRealHigh
2.035.038.03
Details
Naive
Forecast
LowNextHigh
2.895.898.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Zhejiang Hisoar. Your research has to be compared to or analyzed against Zhejiang Hisoar's peers to derive any actionable benefits. When done correctly, Zhejiang Hisoar's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Zhejiang Hisoar Phar.

Zhejiang Hisoar Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Zhejiang Hisoar is not an exception. The market had few large corrections towards the Zhejiang Hisoar's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zhejiang Hisoar Pharmaceutical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zhejiang Hisoar within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.36
β
Beta against Dow Jones-0.92
σ
Overall volatility
0.37
Ir
Information ratio 0.05

Zhejiang Hisoar Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zhejiang Hisoar for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zhejiang Hisoar Phar can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
The company reported the revenue of 2.17 B. Net Loss for the year was (420.06 M) with profit before overhead, payroll, taxes, and interest of 680.2 M.
About 52.0% of the company shares are owned by insiders or employees

Zhejiang Hisoar Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zhejiang Stock often depends not only on the future outlook of the current and potential Zhejiang Hisoar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zhejiang Hisoar's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.6 B

Zhejiang Hisoar Technical Analysis

Zhejiang Hisoar's future price can be derived by breaking down and analyzing its technical indicators over time. Zhejiang Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Zhejiang Hisoar Pharmaceutical. In general, you should focus on analyzing Zhejiang Stock price patterns and their correlations with different microeconomic environments and drivers.

Zhejiang Hisoar Predictive Forecast Models

Zhejiang Hisoar's time-series forecasting models is one of many Zhejiang Hisoar's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Zhejiang Hisoar's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Zhejiang Hisoar Phar

Checking the ongoing alerts about Zhejiang Hisoar for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Zhejiang Hisoar Phar help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
The company reported the revenue of 2.17 B. Net Loss for the year was (420.06 M) with profit before overhead, payroll, taxes, and interest of 680.2 M.
About 52.0% of the company shares are owned by insiders or employees

Other Information on Investing in Zhejiang Stock

Zhejiang Hisoar financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Hisoar security.